Press Releases

BURLINGTON, Mass.--(BUSINESS WIRE)-- Everbridge, Inc. (NASDAQ:EVBG), the global leader in critical event management and enterprise safety software applications to help

LONG BEACH, Calif.--(BUSINESS WIRE)-- Molina Healthcare, Inc. (NYSE: MOH) today announced that it has completed the sale of Pathways Health and Community Support, LLC, a provider of home and community-based human services, to Atar Capital, LLC, a global private investment firm. As part of Molina Healthcare’s renewed focus on its health plan business and continued execution of its margin recover

LOS ANGELES--(BUSINESS WIRE)-- HyreCar Inc. (Nasdaq: HYRE), the carsharing marketplace for ridesharing, announced that key executives Mike Furnari (Chief Business Development Officer) and John Possumato (DriveItAway/HyreCar Commercial Solutions President), will be speaking about dealer opportunities in ridesharing and Mobility as a Service (MaaS) at upcoming automotive industry conferences. Po

ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, announced today that updated re

RESEARCH TRIANGLE PARK, N.C. & AUSTIN, Texas--(BUSINESS WIRE)-- RTI International, a leading non- profit research institute, and Asuragen, a molecular diagnostics product company, announced today their scientific collaboration using a new, high performance screening technology to test for fragile X syndrome in newborns. The technology will be utilized via high throughput process in North Carolina’s Early

HAYWARD, Calif.--(BUSINESS WIRE)-- Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced the appointment of Kristen M. Hege, M.D., to its Board of Directors. Dr. Hege brings more than 20 years of oncology clinical leadership experience to Arcus’s board. “We are thrilled to welcome Dr. Hege to

ALAMEDA, Calif.--(BUSINESS WIRE)-- Exelixis, Inc. (NASDAQ:EXEL) today announced results from the dose-escalation stage of the phase 1b COSMIC-021 study of cabozantinib in co

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca will present new research spanning the Company’s Cardiovascular, Renal and Metabolism (CVRM) therapy area at the American Society of Nephrology (ASN) Kidney Week Annual Meeting in San Diego, US, October 23-28, 2018. ASN Kidney Week is a landmark meeting for AstraZeneca, which will provide new and in-depth research aiming to inform clinical practic

EXTON, Pa.--(BUSINESS WIRE)-- Bentley Systems, Incorporated, the leading global provider of comprehensive software solutions for advancing the design, construction, and operations of infrastructure, has announced the winners of the Year in Infrastructure 2018 Awards. The annual awards program honors the extraordinary work of Bentley users advancing design, construction, and operations of infrastructure t

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced the first results from the IMpassion130 study evaluating ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with atezolizumab (Tecentriq®) in patients with first-line locally advanced triple negative breast cancer (TNBC) and the IMpower130 study eva

MEMPHIS, Tenn.--(BUSINESS WIRE)-- GTx, Inc. (Nasdaq: GTXI) today reported financial results for the third quarter ended September 30, 2018, and provided a corporate update. “During the quarter, we turned our focus to the ongoing selective androgen receptor degrader program and the potential of our novel selective androgen receptor degrader to treat castration-resistant prostate cancer. We expec

KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the first presentation of interim data from the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, as both monotherapy and in combination with chemotherapy, for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma (

MINNEAPOLIS--(BUSINESS WIRE)-- Donaldson Company, Inc. (NYSE: DCI), a leader in the global filtration market, completed its previously announced acquisition of an 88 percent ownership stake in BOFA International LTD (BOFA) last Thursday, October 18. BOFA sells fume extraction systems to OEM customers, distributors and end users, and has recurring sales of replacement filters. Its fume extracti

MALVERN, Pa.--(BUSINESS WIRE)-- PQ Group Holdings Inc. (NYSE:PQG), a leading, integrated global provider of specialty catalysts, materials, chemicals and services, today announced that it plans to release its third quarter 2018 financial results on Tuesday, November 6, 2018, pre-market open. Management will review the results during a conference call and audio-only webcast scheduled for 11:00 a.m. eastern time.

CHICAGO--(BUSINESS WIRE)-- Atlas Financial Holdings, Inc. (NASDAQ:AFH) ("Atlas" or the "Company") is pleased to confirm the approval of its mobile phone driven usage-based commercial automobile product from both an insurance regulatory and technology platform perspective. This straightforward product is the first of its kind for part time Transportation Network (TNC) or “ride share” drivers a